HCV clearance from saliva of HIV–HCV‐coinfected patients on treatment with interferon plus ribavirin. (22nd April 2013)
- Record Type:
- Journal Article
- Title:
- HCV clearance from saliva of HIV–HCV‐coinfected patients on treatment with interferon plus ribavirin. (22nd April 2013)
- Main Title:
- HCV clearance from saliva of HIV–HCV‐coinfected patients on treatment with interferon plus ribavirin
- Authors:
- Feijoo, J
Eirea, M
Limeres, J
Abeleira, M
Ramos, I
Ocampo, A
Diz, P - Abstract:
- <abstract abstract-type="main" xml:lang="en" id="odi12116-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="odi12116-sec-0001" sec-type="section"> <title>Objective</title> <p>To determine hepatitis C virus (HCV) RNA clearance from blood and saliva of HIV–HCV‐coinfected patients undergoing combined therapy with pegylated interferon plus ribavirin (PEG‐IFN‐RIB).</p> </sec> <sec id="odi12116-sec-0002" sec-type="section"> <title>Subjects and Methods</title> <p>Study group was formed of 60 HIV‐infected patients with chronic hepatitis C who were starting treatment with PEG‐IFN‐RIB. Blood and saliva samples were taken at baseline, at the end of treatment and 24 and 48 weeks later. A nested RT‐PCR technique was used to detect HCV‐RNA in saliva.</p> </sec> <sec id="odi12116-sec-0003" sec-type="section"> <title>Results</title> <p>HCV‐RNA was detected in saliva at baseline in 64.7% of patients. Thirty‐four patients completed follow‐up. The response rate (undetectable HCV‐RNA) in blood was 79.4% at the end of treatment; 55.8% at 24 weeks after the end of treatment and 50% at 48 weeks. HCV was detected in saliva of 13 (38.2%) patients at the end of treatment and in 18 (52.9%) patients at 24 and 48 weeks later. Concordance of HCV clearance from blood and saliva reached its maximum value at 48 weeks after the end of treatment (odds ratio, 112.51).</p> </sec> <sec id="odi12116-sec-0004" sec-type="section"> <title>Conclusion</title> <p>In HIV–HCV‐coinfected patients<abstract abstract-type="main" xml:lang="en" id="odi12116-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="odi12116-sec-0001" sec-type="section"> <title>Objective</title> <p>To determine hepatitis C virus (HCV) RNA clearance from blood and saliva of HIV–HCV‐coinfected patients undergoing combined therapy with pegylated interferon plus ribavirin (PEG‐IFN‐RIB).</p> </sec> <sec id="odi12116-sec-0002" sec-type="section"> <title>Subjects and Methods</title> <p>Study group was formed of 60 HIV‐infected patients with chronic hepatitis C who were starting treatment with PEG‐IFN‐RIB. Blood and saliva samples were taken at baseline, at the end of treatment and 24 and 48 weeks later. A nested RT‐PCR technique was used to detect HCV‐RNA in saliva.</p> </sec> <sec id="odi12116-sec-0003" sec-type="section"> <title>Results</title> <p>HCV‐RNA was detected in saliva at baseline in 64.7% of patients. Thirty‐four patients completed follow‐up. The response rate (undetectable HCV‐RNA) in blood was 79.4% at the end of treatment; 55.8% at 24 weeks after the end of treatment and 50% at 48 weeks. HCV was detected in saliva of 13 (38.2%) patients at the end of treatment and in 18 (52.9%) patients at 24 and 48 weeks later. Concordance of HCV clearance from blood and saliva reached its maximum value at 48 weeks after the end of treatment (odds ratio, 112.51).</p> </sec> <sec id="odi12116-sec-0004" sec-type="section"> <title>Conclusion</title> <p>In HIV–HCV‐coinfected patients responders to PEG‐IFN‐RIB, the salivary glands do not appear to be a sanctuary site for HCV, although viral clearance from saliva may be slower than from blood.</p> </sec> </abstract> … (more)
- Is Part Of:
- Oral diseases. Volume 20:Number 3(2014:Apr.)
- Journal:
- Oral diseases
- Issue:
- Volume 20:Number 3(2014:Apr.)
- Issue Display:
- Volume 20, Issue 3 (2014)
- Year:
- 2014
- Volume:
- 20
- Issue:
- 3
- Issue Sort Value:
- 2014-0020-0003-0000
- Page Start:
- 313
- Page End:
- 318
- Publication Date:
- 2013-04-22
- Subjects:
- Mouth -- Diseases -- Research -- Periodicals
617.522 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=1354-523X&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1601-0825 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/odi.12116 ↗
- Languages:
- English
- ISSNs:
- 1354-523X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6277.470000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4178.xml